Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Interest & Investment Income (2016 - 2025)

Pediatrix Medical (MD) has disclosed Interest & Investment Income for 17 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 66.01% to $4.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.0 million, a 230.01% increase, with the full-year FY2025 number at $19.0 million, up 230.01% from a year prior.
  • Interest & Investment Income was $4.7 million for Q4 2025 at Pediatrix Medical, down from $5.9 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $6.0 million in Q1 2021 to a low of -$161000.0 in Q2 2024.
  • A 5-year average of $2.3 million and a median of $1.8 million in 2021 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: crashed 113.54% in 2024, then skyrocketed 2414.91% in 2025.
  • Pediatrix Medical's Interest & Investment Income stood at $1.8 million in 2021, then decreased by 26.77% to $1.3 million in 2022, then skyrocketed by 67.94% to $2.2 million in 2023, then grew by 26.23% to $2.8 million in 2024, then skyrocketed by 66.01% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Interest & Investment Income are $4.7 million (Q4 2025), $5.9 million (Q3 2025), and $3.7 million (Q2 2025).